Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Using molecular data that impacts clinical practice

Is germline testing needed and does it impact treatment decisions?

Date

09 Sep 2022

Session

Using molecular data that impacts clinical practice

Topics

Genetic and Genomic Testing

Tumour Site

Prostate Cancer

Presenters

Elena Castro Marcos

Authors

E. Castro Marcos

Author affiliations

  • Medical Oncology, Hospital Universitario 12 de Octubre, 28041 - Madrid/ES

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Discussion

Presenter: All Speakers

Session: Using molecular data that impacts clinical practice

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.